Renal cell carcinoma on imaging unveiled as a primary Ewing’s sarcoma

Abstract

Background

Ewing sarcoma represents a spectrum of aggressive malignancies with the poor outcome. Primary renal Ewing sarcoma is rare and accounts for less than 1% of renal masses.

Case presentation

We present a case of a 45-year-old male presented in OPD with complaint of right flank pain and hematuria. He underwent a contrast-enhanced CT abdomen which depicted a right renal mass with liver lesions. He underwent Robotic Right Radical Nephrectomy and a pathological diagnosis of Ewing Sarcoma was made after which he was started on chemotherapy.

Conclusions

Owing to presentation in younger age group with poor prognosis, an integrated analysis including radiological imaging, histopathology, and immune-histological staining is essential for early detection of renal Ewing sarcoma.

Background

Ewing sarcoma also called as primitive neuroectodermal tumors (PNET) is a group of small round cell tumor that are typically encountered in the bone and soft tissue of young adults and children. They rarely present as a primary renal tumor [1]. Primary renal Ewing sarcomas/PNET were first reported by Seemayer and colleagues in 1975 [2]. These lesions are often silent and are discovered once the tumor enlarges to cause mass effect, pain, swelling or sometimes hematuria.

These tumors are characterized by an aggressive clinical course with local recurrence and early metastasis, resulting in a very poor prognosis, and thus, early recognition of these are essential [3].

Case presentation

A 45-year-old male presented to the surgical oncology department with the complaints of pain in right flank and hematuria. The general physical was unremarkable. Chest examination revealed normal air entry bilaterally. Neurological examination was also unremarkable. Renal function tests were normal.

Patient underwent a contrast-enhanced computed tomography of the abdomen which revealed an ill-defined hypo-enhancing infiltrative mass predominantly involving the middle and lower pole of the right kidney. It was reaching up to the renal hilum with evidence of tumor thrombus in the right renal vein, extending into the infra hepatic portion of IVC. No areas of internal hemorrhage/calcification or fat density were seen within the mass. Multiple hypodense lesions were seen in both lobes of the liver. Based on the imaging findings, a provisional diagnosis of renal cell carcinoma with liver metastasis was made.

Management and outcome

Patient underwent Robotic Right Radical Nephrectomy with IVC thrombectomy. Light microscopy showed multiple small round blue cells with a high nucleocytoplasmic ratio, arranged in sheets. On immunohistochemistry, tumor cells were positive for NKX2.2 and CD99 and were negative for synaptophysin, INSM1, CK, CK7, 2SC, AMACR with absent rhabdoid features. Final opinion of Ewing sarcoma was made. Patient was started on VAC-based chemotherapy including vincristine, actinomycin and cyclophosphamide.

Discussion

Approximately 90% malignant neoplasms of the kidney are renal cell carcinoma out of which clear cell carcinomas are the most common. Primary renal sarcomas are rare mesenchymal tumors with a reported incidence < 1% of all renal malignancies [4]. Renal PNET mainly affects younger age group, with mean presentation aged 28–34 years and having slightly male predominance [5] Sarcomas of the kidney are usually asymptomatic but when they become enlarged they can produce nonspecific symptoms such as pain, palpable masses and hematuria. The imaging characteristics of Ewing sarcomas are similar to that of RCC [5].

On ultrasound, renal Ewing’s sarcoma/PNET may be hypoechoic, or hyperechoic to the adjacent renal parenchyma with areas of necrosis. These are vascular tumors and thus demonstrate increased vascularity on color Doppler imaging [5]. On post-contrast CT, these appears heterogeneous density mass with necrotic or hemorrhagic areas and have heterogeneous enhancement [5]. Calcification may be present in some cases. Similar to renal cell carcinoma renal vein & IVC involvement can be seen in the Ewing sarcoma [5] On MRI, the tumor masses can appear lobulated with an isointense or hypointense appearance on T1-weighted images with a heterogeneous to hyperintense appearance on T2-weighted images. On post-gadolinium T1-weighted images, this tumor shows heterogeneous enhancement. Similar imaging features may be seen in the other renal tumors, including renal cell carcinoma, Wilms’s tumor, neuroblastoma, lymphoma, renal sarcomas, and metastatic carcinoma [6]. Few imaging features of a renal EWS differentiating it from advanced RCC include the presence of multiple irregular septa seen in both necrotic as well as solid portions of the tumor which are not seen in the advanced RCC [6, 7]. A low enhancement in both the arterial and venous phase favors diagnosis of EWS over large conventional RCCs, which show marked enhancement on the arterial phase and low enhancement on the venous phase. However, low enhancement cannot differentiate with other type of RCC like papillary type and a collecting duct carcinoma [6, 7]. In our case, low enhancement on the arterial and venous phase were seen. It has also been reported that compared to other renal tumors with similar imaging characteristics, the areas of necrosis and hemorrhage seen in renal Ewing's sarcoma ⁄PNET are more commonly located along the periphery of the tumor [8].

Accurate diagnosis of Ewing sarcoma is made either on biopsy material or resected specimen (Fig. 1). On light microscopy small, round cells forming rosettes and pseudorosettes, and fascicular, spindle cell component are seen [3]. Immunohistochemical and molecular studies play a major role in differentiating these tumor types^. In general, Ewing's family tumors show positivity for CD99 (MIC2), FLI-1, vimentin and NSE and are typically negative for pankeratin, desmin, WT-1, GFAP and PAX2. EWSR1/FLI1 fusion product that results from a t (11;22) (q24/q22; q12) translocation. It is seen in the 90% of cases and unequivocally confirms the diagnosis [9]. Current standards of treatments are chemotherapy including vincristine, doxorubicin, and cyclophosphamide, alternating with ifosfamide and etoposide [10]. Despite aggressive treatment (Fig. 2), the prognosis of patients with metastatic disease is poor [3].

Fig. 1 [Images not available. See PDF.]

Axial non-contrast A and contrast-enhanced CT B, C images depicting an ill-defined hypoenhancing infiltrative lesion predominantly involving the middle and lower pole of right kidney reaching up to the renal hilum, D Coronal image shows tumor thrombus in the right renal vein, extending into the infrahepatic portion of IVC. (arrow). E, F Axial image showing few hypodense lesions in both lobes of liver. G, H PET axial image shows metabolic active lesion with heterogeneous tracer uptake in the mid & lower pole of the right kidney (SUV = 4.8)

Fig. 2 [Images not available. See PDF.]

shows a tumor infiltrating the renal parenchyma (A). The tumor shows a nodular pattern of arrangement with surrounding dense fibrous tissue along with entrapment of adjacent renal tubules and glomeruli (right top corner) (B). On high power, the tumor shows a papillary pattern of arrangement with fibro-vascular cores. The tumor cells are small, uniform in size with round nuclei, inconspicuous nucleoli, scant cytoplasm and indistinct cytoplasmic membranes (C, D)

Conclusion

Primitive neuro-ectodermal tumors are an infrequent differential diagnosis in urologic malignancies in younger age group. They have aggressive clinical course and early metastasis. So early diagnosis is crucial for initiation of chemotherapy. Thus, imaging have an important role in diagnosis, staging, and treatment monitoring (Fig. 3). The CT and MRI have role in local assessment of resectability as well as detection of metastases.

Fig. 3 [Images not available. See PDF.]

on immunohistochemistry the tumor cells are immuno-negative for CK A & CK7 B. Few entrapped renal tubules (on right side) show expression with both markers acting as internal control. AMACR C expression is negative in tumor cells. Strong and diffuse immune-expression is seen with CD99 D & NKX2.2 E

Acknowledgements

Not applicable.

Author contributions

SG involved in conception & design of work, drafting the work and manuscript preparation. TK performed manuscript reviewing and editing. SP did final review of the work and approval to be published. All authors read and approved the final manuscript.

Funding

Not applicable.

Availability of data and materials

Not applicable.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Consent was obtained from patient.

Competing interests

All authors have declared that they have no competing interest.

Abbreviations

EWS

Ewing’s sarcoma

PNET

Primitive neuroectodermal tumor

CT

Computed tomography

IVC

Inferior vena cava

RCC

Renal cell carcinoma

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Cheng, L; Xu, Y; Song, H et al. A rare entity of Primary Ewing sarcoma in kidney. BMC Surg; 2020; 20, 280. [DOI: https://dx.doi.org/10.1186/s12893-020-00948-9]

2. Bilgetekin, I; Karaca, M; Gönül, II; Üner, A; Şahinli, H; Demir, H; Aytekin, A; Çiltaû, A; Benekli, M. Ewing's sarcoma of kidney in a 60-year-old patient with local recurrence: a rare occurrence. J Cancer Res Ther; 2018; 14, 6 pp. 1422-1424. [DOI: https://dx.doi.org/10.4103/0973-1482.191062]

3. Angel, JR; Alfred, A; Sakhuja, A et al. Ewing’s sarcoma of the kidney. Int J Clin Oncol; 2010; 15, pp. 314-318. [DOI: https://dx.doi.org/10.1007/s10147-010-0042-0]

4. Uhlig, J; Uhlig, A; Bachanek, S. Mehmet Ruhi Onur, Sonja Kinner, Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors. Eur Radiol; 2022; 32, 2 pp. 981-989. [DOI: https://dx.doi.org/10.1007/s00330-021-08201-4]

5. Almeida MF, Patnana M, Korivi BR, Kalhor N, Marcal L, (2014) Ewing sarcoma of the kidney: a rare entity, Case Rep Radiol. 5

6. Zhang, D; Li, Z; Gao, D; Yang, G; Ding, Y; Wang, G; Dong, X. The CT and US features of Ewing’s sarcoma/primary neuroectodermal tumor of the kidney: two case reports and review of literature. Onco Targets Ther; 2016; 9, pp. 1599-2160.[COI: 1:CAS:528:DC%2BC1cXmsVKntbw%3D]

7. Lee, H; Cho, JY; Kim, SH; Jung, DC; Kim, JK; Choi, HJ. Imaging findings of primitive neuroectodermal tumors of the kidney. J Comput Assist Tomogr; 2009; 33, 6 pp. 882-886. [DOI: https://dx.doi.org/10.1097/RCT.0b013e31819e938b]

8. Wu, CF; Wang, LJ; Chen, CS. Images in clinical urology. Magnetic resonance imaging of primitive neuroectodermal tumor of the kidney. Urology; 2000; 55, 2 pp. 284-285.[COI: 1:STN:280:DC%2BD3c7ltVyjtg%3D%3D] [DOI: https://dx.doi.org/10.1016/S0090-4295(99)00467-7]

9. Katkar, AS; Vinu-Nair, S; Savage, J; Chintapalli, K. Primary renal ewings sarcoma/primitive neuroectodermal tumor (PNET) of the kidney, can it be diagnosed on imaging? a case report. Austin J Radiol; 2014; 1, 1 4.

10. Grier, HE; Krailo, MD; Tarbell, NJ et al. Addition of if-osfamide and etoposide to standard chemotherapy for Ewing’ssarcoma and primitive neuroectodermal tumor of bone. N Engl J Med; 2003; 348, pp. 694-701.[COI: 1:CAS:528:DC%2BD3sXhtlWjt70%3D] [DOI: https://dx.doi.org/10.1056/NEJMoa020890]